Nigeria, Sept. 27 -- Former Kwara State Governor, Abdulfatah Ahmed, and former House of Representatives member, Abubakar Amuda-Kannike, have been appointed to key positions in the African Democratic C... Read More
लखनऊ, सितम्बर 27 -- UP BJP News: यूपी के सियासी हलकों में इन दिनों प्रदेश कोटे की 10 राज्यसभा सीटों को लेकर हलचल तेज है। भाजपा इन सीटों पर प्रत्याशियों के ऐलान में एक बार फिर चौंका सकती है। पार्टी की ... Read More
Kolkata, Sept. 27 -- Mamata All India Trinamool Congress MLA Kunal Ghosh on Sunday that he was targeted in a fresh attack in Kolkata, claiming that armed men smashed the window of his car and attempte... Read More
India, Sept. 27 -- Good morning, readers. Here's your roundup of today's top stories in politics, world affairs, sports, and entertainment - everything you need to start your day informed. External a... Read More
New Delhi, Sept. 27 -- The National Testing Agency (NTA) has moved its confidential and sensitive operations to a new office in central Delhi, where 39 Central Industrial Security Force (CISF) personn... Read More
New Delhi, Sept. 27 -- Americans will soon get an extra hour overnight as daylight saving time comes to an end, with clocks set to "fall back" by one hour on Sunday, 1 November. According to Timeandd... Read More
New Delhi, Sept. 27 -- A road inspection by Delhi PWD Minister Parvesh Sahib Singh Verma in west Delhi's Tilak Nagar on Sunday turned contentious after a video surfaced purportedly showing him slappin... Read More
New Delhi, Sept. 27 -- Chief Minister Rekha Gupta on Sunday hit out at the Opposition over its allegations against the Election Commission and the electoral process, accusing it of creating "baseless"... Read More
New Delhi, Sept. 27 -- The Aam Aadmi Party (AAP) on Sunday held a protest in west Delhi's Tilak Nagar, demanding registration of an FIR against Delhi PWD Minister Parvesh Sahib Verma over an alleged s... Read More
India, Sept. 27 -- Milestone Pharmaceuticals Inc. (MIST), a biopharmaceutical company, on Friday announced the enrollment of the first patient in the Canadian site of the Phase 3 ReVeRA-301 trial eval... Read More